Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126600023 | 12660002 | 3 | F | 201606 | 20160827 | 20160817 | 20160830 | EXP | FR-PFIZER INC-2016382563 | PFIZER | 78.00 | YR | M | Y | 0.00000 | 20160830 | OT | FR | FR |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126600023 | 12660002 | 1 | PS | Triatec | RAMIPRIL | 1 | Oral | 2.5 MG, 2X/DAY | 19901 | 2.5 | MG | TABLET | BID | ||||||
| 126600023 | 12660002 | 2 | SS | TAHOR | ATORVASTATIN CALCIUM | 1 | Oral | 10 MG, DAILY | 20702 | 10 | MG | FILM-COATED TABLET | |||||||
| 126600023 | 12660002 | 3 | SS | PARACETAMOL | ACETAMINOPHEN | 1 | Oral | 1 G, 3X/DAY | 0 | 1 | G | TID | |||||||
| 126600023 | 12660002 | 4 | SS | GABAPENTIN. | GABAPENTIN | 1 | Oral | 300 MG, 3X/DAY | 20235 | 300 | MG | CAPSULE, HARD | TID | ||||||
| 126600023 | 12660002 | 5 | SS | BISOPROLOL FUMARATE. | BISOPROLOL FUMARATE | 1 | Oral | 5 MG, DAILY | 0 | 5 | MG | FILM-COATED TABLET | |||||||
| 126600023 | 12660002 | 6 | SS | ALLOPURINOL. | ALLOPURINOL | 1 | Oral | 100 MG, DAILY | 0 | 100 | MG | TABLET | |||||||
| 126600023 | 12660002 | 7 | SS | REPAGLINIDE. | REPAGLINIDE | 1 | Oral | 0.5 MG, 2X/DAY | 0 | .5 | MG | TABLET | BID | ||||||
| 126600023 | 12660002 | 8 | SS | PREVISCAN | FLUINDIONE | 1 | Oral | 15 MG, ALTERNATE DAY | 0 | 15 | MG | TABLET | QOD | ||||||
| 126600023 | 12660002 | 9 | SS | PREVISCAN | FLUINDIONE | 1 | Oral | 20 MG, ALTERNATE DAY | 0 | 20 | MG | TABLET | QOD | ||||||
| 126600023 | 12660002 | 10 | SS | SPIRIVA | TIOTROPIUM BROMIDE MONOHYDRATE | 1 | Respiratory (inhalation) | 5 MG, DAILY | 0 | 5 | MG | ||||||||
| 126600023 | 12660002 | 11 | SS | DIGOXINE NATIVELLE | DIGOXIN | 1 | Oral | 0.25 MG, DAILY | 0 | .25 | MG | TABLET | |||||||
| 126600023 | 12660002 | 12 | SS | AERIUS | DESLORATADINE | 1 | Oral | 5 MG, 2X/DAY | 0 | 5 | MG | BID | |||||||
| 126600023 | 12660002 | 13 | SS | FLUTIFORM | FLUTICASONE PROPIONATEFORMOTEROL FUMARATE | 1 | Respiratory (inhalation) | 2 DF, 2X/DAY | 0 | 2 | DF | BID | |||||||
| 126600023 | 12660002 | 14 | SS | VENTOLINE | ALBUTEROL | 1 | Respiratory (inhalation) | 100 MG, AS NEEDED | 0 | 100 | MG |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 126600023 | 12660002 | 1 | Hypertension |
| 126600023 | 12660002 | 2 | Hypercholesterolaemia |
| 126600023 | 12660002 | 3 | Pain |
| 126600023 | 12660002 | 5 | Hypertension |
| 126600023 | 12660002 | 6 | Hyperuricaemia |
| 126600023 | 12660002 | 7 | Type 2 diabetes mellitus |
| 126600023 | 12660002 | 8 | Thrombosis prophylaxis |
| 126600023 | 12660002 | 10 | Asthma |
| 126600023 | 12660002 | 11 | Atrial fibrillation |
| 126600023 | 12660002 | 13 | Asthma |
| 126600023 | 12660002 | 14 | Asthmatic crisis |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 126600023 | 12660002 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 126600023 | 12660002 | Eosinophilia | |
| 126600023 | 12660002 | Lung disorder | |
| 126600023 | 12660002 | Pleural effusion |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |